Vitamin D supplementation inhibits oxidative stress and upregulate SIRT1/AMPK/GLUT4 cascade in high glucose-treated 3T3L1 adipocytes and in adipose tissue of high fat diet-fed diabetic mice

Archives of Biochemistry and Biophysics

Volumn 615, Issue , 2017, Pages 22-34

  Manna, Prasenjit ^a   Achari, Arunkumar E ^a   Jain, Sushil K ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Glucose metabolism; High glucose; Oxidative stress; SIRT1 AMPK IRS1 GLUT4; Vitamin D

Indexed keywords

ADENYLATE KINASE; BETA ACTIN; CALCITRIOL; COLECALCIFEROL; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C GAMMA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SIRTUIN 1; SMALL INTERFERING RNA; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; CALCITRIOL RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRT1 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE; VITAMIN D;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITAMIN SUPPLEMENTATION; 3T3-L1 CELL LINE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DIETARY SUPPLEMENT; EXPERIMENTAL DIABETES MELLITUS; FIBROBLAST; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FIBROBLASTS; GLUCOSE TRANSPORTER TYPE 4; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RECEPTORS, CALCITRIOL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; UP-REGULATION; VITAMIN D;

EID: 85008625948     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2017.01.002     Document Type: Article

References (56)

1. [1] Rosen, C.J., Adams, J.S., Bikle, D.D., Black, D.M., Demay, M.B., Manson, J.E., Murad, M.H., Kovacs, C.S., The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 33:3 (2012), 456–492.
2. [2] Gradinaru, D., Borsa, C., Ionescu, C., Margina, D., Prada, G.I., Jansen, E., Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus. Aging Clin. Exp. Res. 24:6 (2012), 595–602.
3. [3] Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C.R., Burns, K.D., Touyz, R.M., Hebert, R.L., Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 299:6 (2010), F1348–F1358.
4. [4] Jiang, F., Zhang, Y., Dusting, G.J., NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol. Rev. 63:1 (2011), 218–242.
5. [5] Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T.W., Yamamoto, M., The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell Biol. 33:15 (2013), 2996–3010.
6. [6] Jaiswal, A.K., Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36:10 (2004), 1199–1207.
7. [7] Huang, S., Czech, M.P., The GLUT4 glucose transporter. Cell Metab. 5:4 (2007), 237–252.
8. [8] Stenbit, A.E., Tsao, T.S., Li, J., Burcelin, R., Geenen, D.L., Factor, S.M., Houseknecht, K., Katz, E.B., Charron, M.J., GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 3:10 (1997), 1096–1101.
9. [9] Wallberg-Henriksson, H., Zierath, J.R., GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review). Mol. Membr. Biol. 18:3 (2001), 205–211.
10. [10] Chang, L., Chiang, S.H., Saltiel, A.R., Insulin signaling and the regulation of glucose transport. Mol. Med. 10:7–12 (2004), 65–71.
11. [11] Liang, F., Kume, S., Koya, D., SIRT1 and insulin resistance. Nat. Rev. Endocrinol. 5:7 (2009), 367–373.
12. [12] Ruderman, N.B., Carling, D., Prentki, M., Cacicedo, J.M., AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 123:7 (2013), 2764–2772.
13. [13] Chopra, I., Li, H.F., Wang, H., Webster, K.A., Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 55:3 (2012), 783–794.
14. [14] Yoshizaki, T., Milne, J.C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J.L., Lu, J.C., Smith, J.J., Jirousek, M.R., Olefsky, J.M., SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell Biol. 29:5 (2009), 1363–1374.
15. [15] Wang, H., Wang, J., Qu, H., Wei, H., Yang, Z., Wu, J., He, Q., Luo, Y., Liu, D., Duan, Y., In vitro and in vivo inhibition of mTOR by 1, 25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway. Endocrine, 2016, 1–12.
16. [16] Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H.F., Lieben, L., Mathieu, C., Demay, M., Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29:6 (2008), 726–776.
17. [17] Takiishi, T., Gysemans, C., Bouillon, R., Mathieu, C., Vitamin D and diabetes. Endocrinol. metabolism Clin. North America 39:2 (2010), 419–446.
18. [18] Manna, P., Jain, S.K., PIP3 but not PIP2 increases GLUT4 surface expression and glucose metabolism mediated by AKT/PKCzeta/lambda phosphorylation in 3T3L1 adipocytes. Mol. Cell Biochem. 381:1–2 (2013), 291–299.
19. [19] Manna, P., Jain, S.K., Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J. Biol. Chem. 287:50 (2012), 42324–42332.
20. [20] Candiloros, H., Muller, S., Zeghari, N., Donner, M., Drouin, P., Ziegler, O., Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influ. Ket. bodies, Diabetes Care 18:4 (1995), 549–551.
21. [21] Yaturu, S., Davis, J., Prevalence of decreased vitamin D levels is high among veterans with diabetes and/or CKD. ISRN Endocrinol., 2011, 2011, 109458.
22. [22] Manna, P., Jain, S.K., Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Czeta/lambda (PKCzeta/lambda) in 3T3l1 adipocytes. J. Biol. Chem. 286:46 (2011), 39848–39859.
23. [23] Mastroyiannopoulos, N.P., Nicolaou, P., Anayasa, M., Uney, J.B., Phylactou, L.A., Down-regulation of myogenin can reverse terminal muscle cell differentiation. PLoS One, 7(1), 2012 e29896.
24. [24] Koshy, S., Alizadeh, P., Timchenko, L.T., Beeton, C., Quantitative measurement of GLUT4 translocation to the plasma membrane by flow cytometry. JoVE (J. Vis. Exp.)(45), 2010 e2429–e2429.
25. [25] Vishwanath, D., Srinivasan, H., Patil, M.S., Seetarama, S., Agrawal, S.K., Dixit, M.N., Dhar, K., Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog. J. Cell. Commun. Signal. 7:2 (2013), 129–140.
26. [26] Jung, D.W., Ha, H.H., Zheng, X., Chang, Y.T., Williams, D.R., Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects. Mol. BioSyst. 7:2 (2011), 346–358.
27. [27] Manna, P., Jain, S.K., Decreased hepatic phosphatidylinositol-3,4,5-triphosphate (PIP3) levels and impaired glucose homeostasis in type 1 and type 2 diabetic rats. Cell Physiol. Biochem. 30:6 (2012), 1363–1370.
28. [28] S.K. Jain, P. Manna, D. Micinski, B.J. Lieblong, G. Kahlon, L. Morehead, R. Hoeldtke, P.F. Bass Iii, S.N. Levine, In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress?, Antioxidants redox Signal. 18(10) 1154–1158.
29. [29] Rains, J.L., Jain, S.K., Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 50:5 (2011), 567–575.
30. [30] Mitri, J., Muraru, M.D., Pittas, A.G., Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65:9 (2011), 1005–1015.
31. [31] Kabadi, S.M., Lee, B.K., Liu, L., Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care 35:10 (2012), 2048–2054.
32. [32] Schwalfenberg, G., Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion. Can. Fam. Physician 54:6 (2008), 864–866.
33. [33] Aljabri, K.S., Bokhari, S.A., Khan, M.J., Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D. Defic. Ann. Saudi Med. 30:6 (2010), 454–458.
34. [34] Kayaniyil, S., Vieth, R., Retnakaran, R., Knight, J.A., Qi, Y., Gerstein, H.C., Perkins, B.A., Harris, S.B., Zinman, B., Hanley, A.J., Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33:6 (2010), 1379–1381.
35. [35] Li, J., Houseknecht, K.L., Stenbit, A.E., Katz, E.B., Charron, M.J., Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice. FASEB J. 14:9 (2000), 1117–1125.
36. [36] Finkel, T., Deng, C.X., Mostoslavsky, R., Recent progress in the biology and physiology of sirtuins. Nature 460:7255 (2009), 587–591.
37. [37] Haigis, M.C., Guarente, L.P., Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20:21 (2006), 2913–2921.
38. [38] Cohen, H.Y., Miller, C., Bitterman, K.J., Wall, N.R., Hekking, B., Kessler, B., Howitz, K.T., Gorospe, M., de Cabo, R., Sinclair, D.A., Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:5682 (2004), 390–392.
39. [39] Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., Zhai, Q., SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6:4 (2007), 307–319.
40. [40] Steinberg, G.R., Kemp, B.E., AMPK in health and disease. Physiol. Rev. 89:3 (2009), 1025–1078.
41. [41] Hou, X., Xu, S., Maitland-Toolan, K.A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T.J., Cohen, R.A., Zang, M., SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283:29 (2008), 20015–20026.
42. [42] Suchankova, G., Nelson, L.E., Gerhart-Hines, Z., Kelly, M., Gauthier, M.S., Saha, A.K., Ido, Y., Puigserver, P., Ruderman, N.B., Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem. Biophys. Res. Commun. 378:4 (2009), 836–841.
43. [43] Droge, W., Free radicals in the physiological control of cell function. Physiol. Rev. 82:1 (2002), 47–95.
44. [44] Bedard, K., Krause, K.H., NOX Fam. ROS-generating NADPH oxidases physiology Pathophysiol. Physiological Rev. 87:1 (2007), 245–313.
45. [45] Han, C.Y., Umemoto, T., Omer, M., Den Hartigh, L.J., Chiba, T., LeBoeuf, R., Buller, C.L., Sweet, I.R., Pennathur, S., Abel, E.D., Chait, A., NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. J. Biol. Chem. 287:13 (2012), 10379–10393.
46. [46] Jung, K.A., Kwak, M.K., The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15:10 (2010), 7266–7291.
47. [47] Gan, N., Mi, L., Sun, X., Dai, G., Chung, F.L., Song, L., Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response. Toxicol. Appl. Pharmacol. 247:2 (2010), 129–137.
48. [48] Wang, X., Ye, X.L., Liu, R., Chen, H.L., Bai, H., Liang, X., Zhang, X.D., Wang, Z., Li, W.L., Hai, C.X., Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem. Biol. Interact. 184:3 (2010), 328–337.
49. [49] Wang, X., Wang, Z., Liu, J.Z., Hu, J.X., Chen, H.L., Li, W.L., Hai, C.X., Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Toxicol Vitro 25:4 (2011), 839–847.
50. [50] Kato, S., The function of vitamin D receptor in vitamin D action. J. Biochem. 127:5 (2000), 717–722.
51. [51] O'Neill, H.M., AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes Metab. J. 37:1 (2013), 1–21.
52. [52] Ruderman, N.B., Xu, X.J., Nelson, L., Cacicedo, J.M., Saha, A.K., Lan, F., Ido, Y., AMPK and SIRT1: a long-standing partnership?. Am. J. Physiology-Endocrinology Metabolism 298:4 (2010), E751–E760.
53. [53] Lan, F., Cacicedo, J.M., Ruderman, N., Ido, Y., SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283:41 (2008), 27628–27635.
54. [54] Hou, X., Xu, S., Maitland-Toolan, K.A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T.J., SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283:29 (2008), 20015–20026.
55. [55] Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J.S., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell metab. 15:5 (2012), 675–690.
56. [56] Cantó, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., Auwerx, J., AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:7241 (2009), 1056–1060.